| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/08/2011 | CN101080404B Pyrimidinylisoxazol derivative |
| 06/08/2011 | CN101068827B Polymorphs of sarsasapogenin |
| 06/07/2011 | US7956219 Amino acid analogues |
| 06/07/2011 | US7956187 Method for decreasing opioid metabolism |
| 06/07/2011 | US7956091 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 06/07/2011 | US7956075 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/07/2011 | US7956061 Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 06/07/2011 | US7956038 GASP1: a follistatin domain containing protein |
| 06/07/2011 | CA2613155C Substituted cyclobutane,its preparation process and its medical use |
| 06/07/2011 | CA2574721C Ngna compositions and methods of use |
| 06/07/2011 | CA2555824C Fused-ring 4-oxopyrimidine derivative |
| 06/07/2011 | CA2521732C Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists |
| 06/07/2011 | CA2483164C Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 06/07/2011 | CA2471144C Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| 06/07/2011 | CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/07/2011 | CA2444046C Use of colesevelam in reducing serum glucose |
| 06/07/2011 | CA2435685C Desaturase genes and uses thereof |
| 06/07/2011 | CA2434035C Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome |
| 06/07/2011 | CA2377627C Cartilage enhancing food supplements and methods of preparing the same |
| 06/07/2011 | CA2306216C The use of inhibitors of the renin-angiotensin system for the treatment of cachexia and wasting |
| 06/07/2011 | CA2213759C Method for treating amyloidosis |
| 06/06/2011 | WO2010068580A1 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 06/06/2011 | CA2745882A1 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 06/03/2011 | WO2011066567A1 Methods of treating diabetes |
| 06/03/2011 | WO2011066484A2 Isoxazoline compounds in type 2 diabetes and other maladies |
| 06/03/2011 | WO2011066183A1 Novel spiropiperidine compounds |
| 06/03/2011 | WO2011065880A1 Dietary fibre composition containing beta-glucan |
| 06/03/2011 | WO2011065552A1 Nutritional composition beneficial to small intestine |
| 06/03/2011 | WO2011065420A1 Method for manufacturing a 6-substituted-1-methyl-1h-benzimidazole derivative, and manufacturing intermediate from said method |
| 06/03/2011 | WO2011065389A1 Method for screening of therapeutic agent for hyperlipemia |
| 06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
| 06/03/2011 | WO2011063597A1 Complex microbial preparation for treating diabetes and preparative method and use thereof |
| 06/03/2011 | WO2011063549A1 Long-acting exendin 4 analogues |
| 06/03/2011 | WO2011033225A3 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/03/2011 | WO2011017054A3 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 06/03/2011 | WO2010135429A8 Compositions for modulating a kinase cascade and methods of use thereof |
| 06/03/2011 | WO2008151415A8 Combination for treatment of diabetes mellitus |
| 06/03/2011 | CA2781800A1 Method for manufacturing a 6-substituted 1-methyl-1h-benzimidazole derivative and an intermediate of said method |
| 06/03/2011 | CA2781292A1 Novel spiropiperidine compounds |
| 06/02/2011 | US20110130783 Treatment of obesity and related disorders |
| 06/02/2011 | US20110130637 Protein product for modifying cardiovascular health |
| 06/02/2011 | US20110130464 Combination Agent for Improving Carcass Performance in Finishing Pigs |
| 06/02/2011 | US20110130458 Krill oil process |
| 06/02/2011 | US20110130450 Pravastatin extraction |
| 06/02/2011 | US20110130448 Functionalized phenolic esters and amides and polymers therefrom |
| 06/02/2011 | US20110130438 Aniline analogs as glycogen synthase activators |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130424 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 06/02/2011 | US20110130420 Isoquinolinone derivatives as nk3 antagonists |
| 06/02/2011 | US20110130417 New azacyclic derivatives |
| 06/02/2011 | US20110130416 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 06/02/2011 | US20110130415 Protein kinase c inhibitors and uses thereof |
| 06/02/2011 | US20110130409 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 06/02/2011 | US20110130407 Isoquinolinone derivatives as nk3 antagonists |
| 06/02/2011 | US20110130404 Quinoxalinedione derivatives |
| 06/02/2011 | US20110130402 Heteroaromatic glucokinase activators |
| 06/02/2011 | US20110130395 P13k isoform selective inhibitors |
| 06/02/2011 | US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 06/02/2011 | US20110130387 Sirtuin modulating compounds |
| 06/02/2011 | US20110130385 Bicyclic Heterocylic Derivatives and Methods of Use |
| 06/02/2011 | US20110130382 Modulators of 5-ht receptors and methods of use thereof |
| 06/02/2011 | US20110130380 Heteroaryl Kinase Inhibitors |
| 06/02/2011 | US20110130378 Ezetimibe process and composition |
| 06/02/2011 | US20110130377 Substituted aryloxazoles and their use |
| 06/02/2011 | US20110130373 Methods for administration and formulations for the treatment of regional adipose tissue |
| 06/02/2011 | US20110130365 Fluorinated Heteroaryls |
| 06/02/2011 | US20110130362 A2b adenosine receptor antagonists |
| 06/02/2011 | US20110130354 Sulfated oligosaccharide derivatives |
| 06/02/2011 | US20110130352 The use of the effective fraction of alkaloids from mulberry twig in preparing hypoglycemic agents |
| 06/02/2011 | US20110130331 Modified growth hormones |
| 06/02/2011 | US20110130330 Topical Drug Delivery Using Phosphatidylcholine |
| 06/02/2011 | US20110130329 Glp-1 Fusion Peptides, Their Production and Use |
| 06/02/2011 | US20110129896 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3Beta PROTEIN AND PROTEIN COMPLEXES |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129548 Immunopotentiating Compositions Comprising Beta-1, 3/1, 6-D-Glucan and Uses Thereof |
| 06/02/2011 | US20110129542 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 06/02/2011 | US20110129530 Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture |
| 06/02/2011 | US20110129528 Sustained-release chitosan capsules comprising chitosan and phytic acid |
| 06/02/2011 | US20110129523 Liposomally Encapsulated Reduced Glutathione, including with Other Pharmacologic Preparation, Capable of Administration as an Oral, Topical, Intraoral or Transmucosal, Prepartion, for Reversal and Prevention of Oxidation of Cholesterol and of Low Density Lipoprotein |
| 06/02/2011 | US20110129522 Transdermal system for extended delivery of incretins and incretn mimetic peptides |
| 06/02/2011 | US20110129504 Composition for controlling lipase catalyzed reactions |
| 06/02/2011 | US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110129447 Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy |
| 06/02/2011 | US20110129428 Safflower with Elevated Gamma-Linolenic Acid |
| 06/01/2011 | EP2327712A2 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 06/01/2011 | EP2327698A1 Process for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate |
| 06/01/2011 | EP2327690A1 Tricyclic compound |
| 06/01/2011 | EP2327409A1 Tetracycline compound having target therapeutic activities |
| 06/01/2011 | EP2327399A1 Treatment of hypertension |
| 06/01/2011 | EP2326668A1 Anti-il-12/il-23 antibodies |
| 06/01/2011 | EP2326650A2 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 06/01/2011 | EP2326649A1 Novel pyrrolo ý2,3-a¨carbazoles and use thereof as pim kinase inhibitors |
| 06/01/2011 | EP2326632A2 Novel choline cocrystal of epalrestat |
| 06/01/2011 | EP2326618A1 Glucagon antagonists |
| 06/01/2011 | EP2326315A1 Treatment of an autoimmune disease using il-18 antagonists |
| 06/01/2011 | EP1584925B1 Novel screening method |
| 06/01/2011 | CN1997370B Use of n-sulfamoyl-n'-arylpiperazines in preparing medicine for the prophylaxis or treatment of obesity and related conditions |
| 06/01/2011 | CN1989090B Cis-1,2-substituted diphenyl ethylene derivatives and its use in preparing medine for treating and/or preventing diabetes |
| 06/01/2011 | CN1934103B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 06/01/2011 | CN1893837B Serum remnant-like lipoprotein concentration regulator |